SPG7 and coronary artery disorder: Hence, we propose these two TCM compounds, saussureamine C and 3-(2-carboxyphenyl)-4(3H)-quinazolinone, as potential lead drug candidates isolated from TCMs for further study in the drug development process with paraplegin protein for coronary artery disease.